BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23920063)

  • 21. Effect of a serine protease inhibitor on the progression of chronic renal failure.
    Hayata M; Kakizoe Y; Uchimura K; Morinaga J; Yamazoe R; Mizumoto T; Onoue T; Ueda M; Shiraishi N; Adachi M; Miyoshi T; Sakai Y; Tomita K; Kitamura K
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1126-35. PubMed ID: 22832926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-Regulation of Cardiac Erythropoietin Receptor and its Downstream Activated Signal Transducer Phospho-STAT-5 in a Rat Model of Chronic Kidney Disease.
    Hertzberg-Bigelman E; Barashi R; Levy R; Cohen L; Ben-Shoshan J; Keren G; Entin-Meer M
    Isr Med Assoc J; 2016 Jun; 18(6):326-30. PubMed ID: 27468524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
    Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
    J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure.
    Amann K; Törnig J; Buzello M; Kuhlmann A; Gross ML; Adamczak M; Buzello M; Ritz E
    Kidney Int; 2002 Sep; 62(3):877-84. PubMed ID: 12164869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM; Robertson SJ; Burns KD; deBlois D
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
    Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats.
    Serizawa K; Yogo K; Tashiro Y; Aizawa K; Kawasaki R; Hirata M; Endo K
    Eur J Pharmacol; 2015 Nov; 767():10-6. PubMed ID: 26432688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopeptidase inhibition has beneficial cardiac effects in spontaneously diabetic Goto-Kakizaki rats.
    Grönholm T; Cheng ZJ; Palojoki E; Eriksson A; Bäcklund T; Vuolteenaho O; Finckenberg P; Laine M; Mervaala E; Tikkanen I
    Eur J Pharmacol; 2005 Sep; 519(3):267-76. PubMed ID: 16137672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats.
    Ghosh SS; Salloum FN; Abbate A; Krieg R; Sica DA; Gehr TW; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H975-84. PubMed ID: 20601462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rats?
    Liu WH; Tang NN; Zhang QD
    Chin Med J (Engl); 2009 Jan; 122(2):199-204. PubMed ID: 19187647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin?
    Amann K; Buzello M; Simonaviciene A; Miltenberger-Miltenyi G; Koch A; Nabokov A; Gross ML; Gless B; Mall G; Ritz E
    Nephrol Dial Transplant; 2000 Jul; 15(7):964-9. PubMed ID: 10862632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enalapril inhibits growth and proliferation of various tissues in rat normotensive four-sixths kidney ablation nephropathy.
    Gajdos M; Krivosíková Z; Sebeková K; Lajdová I; Spustová V; Dzúrik R
    Kidney Blood Press Res; 2000; 23(2):106-12. PubMed ID: 10765112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enalapril reduces the expression of nuclear factor-kappaB and c-Jun N-terminal kinase in the renal cortices of five-sixths-nephrectomized rats.
    Costa JC; Costa RS; Silva CG; Coimbra TM
    Am J Nephrol; 2006; 26(3):281-6. PubMed ID: 16772709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
    J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease.
    Shiraishi T; Tamura Y; Taniguchi K; Higaki M; Ueda S; Shima T; Nagura M; Nakagawa T; Johnson RJ; Uchida S
    Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1313-22. PubMed ID: 25320353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function.
    Pessoa FG; Mady C; Fonseca KCB; de Oliveira-Fonoff AM; Salemi VMC; Jordão MR; Fernandes F; Ramires FJA
    Can J Physiol Pharmacol; 2018 Jun; 96(6):541-549. PubMed ID: 29120671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardioprotective effect of calcineurin inhibition in an animal model of renal disease.
    Di Marco GS; Reuter S; Kentrup D; Ting L; Ting L; Grabner A; Jacobi AM; Pavenstädt H; Baba HA; Tiemann K; Brand M
    Eur Heart J; 2011 Aug; 32(15):1935-45. PubMed ID: 21138940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.